CCR-7 EVs
€4,500.00
Tax excluded
EVs bioengineered with human CCR-7 GPCR
CCR-7 EVs, innovative bioengineered EVs harbouring CCR-7 (human C-C chemokine receptor type 7) GPCR
CCR-7 EVs are produced by human embryonic kidney (HEK) 293T cells and purified according to in-EV purification process. These pure EVs are characterised using standardised quality controls. CCR-7 GPCR is targeted to the EV membrane using Ciloa technology, which does not overexpress or modify natural EV proteins.
CCR-7 EVs are interesting tools that can be used to:
- Study molecular interactions with ligands, specific antibodies or small molecules
- Characterise CCR-7 GPCR using technologies like SPR or other
Specifications
| Total protein quantity of pure EVs | 50 µg | 100 µg |
| Particle number (Nano-flow cytometry) | ≥ 1E+10 particles | ≥ 2E+10 particles |
| Particle size (Nano-flow cytometry) | Median size of 60-70 nm | |
| Source | HEK293T cells | |
| Buffer | PBS 1X – BSA 10 µg/mL | |
| Storage | Store sterile at +4°C up to 6 months | |
Strengths of CCR-7 EVs
- 100% fully native GPCR embedded with its right topology on EV membrane.
- Bioengineered EVs using Ciloa technology, no overexpression or modification of natural EV proteins.
- Storage at +4°C, in a simple buffer, for several months when kept sterile.
X137_50